Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

NCT01116193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphoid
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Interventions

DRUG: Lenalidomide plus dexamethasone

Sponsor

Institut de Cancérologie de la Loire

Collaborators

[object Object]